浜у搧璇存槑
涓€鑸弿杩?/p>
Human placental lactogen (hPL), also previously known as "human chorionic somatomammotropin", is a 22 kD protein with partial homology to growth hormone. hPL is first detectable in the maternal serum in the fifth week of gestation and reaches a plateau by the thirty-fourth week. hPL has been demonstrated by immunochemistry in the syncytiotrophoblastic cells of choriocarcinoma. A rare variant of trophoblastic tumor has been reported in the testis with resemblance to uterine placental site trophoblastic tumor. It consists purely of intermediate trophoblasts which are diffusely positive for hPL and focally for ?-hCG.
璐ㄩ噺
![]() IVD |
![]() IVD |
![]() IVD |
![]() RUO |
鑱旂郴
Human Placental Lactogen (hPL) Positive Control Slides, Product No. 266S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
澶栧舰
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
鍒跺璇存槑
Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.
Download the latest released IFU
Note: This IFU may not apply to your specific product lot.
鍏朵粬璇存槑
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
娉曞緥淇℃伅
Cell Marque is a trademark of sigma-aldrich Co. LLC
鍩烘湰淇℃伅
NACRES | NA.41 |
浜у搧鎬ц川
鐢熺墿鏉ユ簮 | rabbit |
璐ㄩ噺姘村钩 | 500 100 |
鍋惰仈鐗?/td> | unconjugated |
鎶椾綋褰㈠紡 | Ig fraction of antiserum |
antibody product type | primary antibodies |
鍏嬮殕 | polyclonal |
鎻忚堪 | For In Vitro Diagnostic Use in Select Regions (See Chart) |
褰㈠紡 | buffered aqueous solution |
species reactivity | human |
鍖呰 | vial of 0.1 mL concentrate (266A-14) vial of 0.5 mL concentrate (266A-15) bottle of 1.0 mL predilute (266A-17) vial of 1.0 mL concentrate (266A-16) bottle of 7.0 mL predilute (266A-18) |
manufacturer/tradename | Cell Marque? |
technique(s) | immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:50-1:200 |
鎺у埗 | placenta |
杩愯緭 | wet ice |
鍌ㄥ瓨娓╁害 | 2-8鈩傸/td> |
鍙鍖朁/td> | cytoplasmic |